Arterial Versus Venous Port Site Administration of Nadroparin for Preventing Thrombosis of Extracorporeal Blood Circuits in Patients Receiving Hemodiafiltration Treatment-Reference-Cited by-同舟云学术

Arterial Versus Venous Port Site Administration of Nadroparin for Preventing Thrombosis of Extracorporeal Blood Circuits in Patients Receiving Hemodiafiltration Treatment

Published:2021-02 Issue:2 Volume:6 Page:351-356
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Hebibi Hedia,Attaf David,Cornillac Laure,Achiche Jejiga,El Boundri Fatia,Francais Patrick,Chazot Charles,Canaud Bernard

Publisher

Elsevier BV

Subject

Nephrology

Reference19 articles.

1. Nadroparin calcium. A review of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disorders;Barradell;Drugs,1992

2. Citrate versus heparin anticoagulation in chronic haemodialysis patients;Janssen;Nephrol Dial Transplant,1993

3. Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis;Lazrak;BMC Nephrol,2017

4. Safety and efficacy of low molecular weight heparins for hemodialysis in patients with end-stage renal failure: a meta-analysis of randomized trials;Lim;J Am Soc Nephrol,2004

5. Low-molecular weight heparin infusion as anticoagulation for haemodialysis;Wong;Clin Kidney J,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood circuit in hemodialysis;Practical Design and Applications of Medical Devices;2024

2. How to Ensure Patency of the Extracorporeal Circuit in Hemodialysis: Global Perspectives;Seminars in Nephrology;2023-11

3. Prescription of online hemodiafiltration (ol‐HDF);Seminars in Dialysis;2022-03-17

4. Comparison of the injection of low‐molecular weight heparin in the arterial vs. venous blood line for preventing extracorporeal circuit clotting during hemodialysis;Hemodialysis International;2022-01-10